Jb Capital LLC Novo Nordisk A S Transaction History

Jb Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$103.24 - $121.81 $12,698 - $14,982	123 Added 2.95%	4,287 $478,000
Q1 2022 Apr 19, 2022	SELL	$93.1 - $112.54 $64,983 - $78,552	-698 Reduced 14.36%	4,164 $463,000
Q4 2021 Feb 02, 2022	BUY	$95.88 - $117.08 $1,054 - $1,287	11 Added 0.23%	4,862 $544,000
Q3 2021 Dec 08, 2021	BUY	$84.42 - $106.62 $409,521 - $517,213	4,851 New	4,851 $466,000

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Jb Capital LLC with notifications on news.